Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Invested Capital (2016 - 2025)

Historic Invested Capital for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $374.1 million.

  • CorMedix's Invested Capital rose 53722.53% to $374.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.1 million, marking a year-over-year increase of 53722.53%. This contributed to the annual value of $84.7 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CorMedix's Invested Capital stood at $374.1 million, which was up 53722.53% from $220.6 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Invested Capital registered a high of $374.1 million during Q3 2025, and its lowest value of $46.2 million during Q2 2024.
  • Over the past 5 years, CorMedix's median Invested Capital value was $62.3 million (recorded in 2021), while the average stood at $92.5 million.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 2943.39% in 2024, then skyrocketed by 53722.53% in 2025.
  • Quarter analysis of 5 years shows CorMedix's Invested Capital stood at $62.8 million in 2021, then decreased by 12.32% to $55.1 million in 2022, then soared by 51.11% to $83.2 million in 2023, then rose by 1.75% to $84.7 million in 2024, then soared by 341.94% to $374.1 million in 2025.
  • Its Invested Capital was $374.1 million in Q3 2025, compared to $220.6 million in Q2 2025 and $114.9 million in Q1 2025.